GoodRx Holdings (GDRX) Other Operating Expenses (2019 - 2026)

GoodRx Holdings has disclosed Other Operating Expenses across 8 years of filings, most recently posting $70.0 million for Q2 2026.

• In Q2 2026, Other Operating Expenses rose 11.06% year-over-year to $70.0 million; the TTM figure through Jun 2026 stood at $277.5 million (up 10.64% YoY), while the FY2025 annual figure was $259.6 million, up 9.55% from the prior year.
• Other Operating Expenses came in at $70.0 million for Q2 2026 at GoodRx Holdings, down from $72.1 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $91.4 million in Q3 2023 to a low of $58.7 million in Q1 2022.
• Average Other Operating Expenses over 5 years is $67.8 million, with a median of $65.6 million recorded in 2025.
• Year-over-year, Other Operating Expenses soared 39.92% in 2022 and tumbled 35.03% in 2024.
• Over 5 years, Other Operating Expenses stood at $69.7 million in 2022, then jumped by 30.36% to $90.8 million in 2023, then tumbled by 30.59% to $63.0 million in 2024, then grew by 10.35% to $69.5 million in 2025, then gained by 0.62% to $70.0 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $70.0 million in Q2 2026, $72.1 million in Q1 2026, and $69.5 million in Q4 2025.